An analysis of the FINEXT-BD data found that individuals with bipolar disorder have a 3.1% risk of cardiovascular events, ...

Two local research institutions have received a multimillion-dollar grant to join a national research network. The University ...

Many go to worship in our best clothes and biggest smiles, in some cases, putting on a show. That’s what Pastor Seth Perry of ...

Many who escalate complaints get insurance denials overturned. Consumer advocates say that’s a clear sign companies routinely deny care they shouldn’t.

Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer side effects.

The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.

Bullish option flow detected in Teva (TEVA) with 17,095 calls trading, 1.7x expected, and implied vol increasing over 1 point to 42.32%. 3/14 ...

By blocking dopamine-1 receptors, ecopipam is expected to reduce the repetitive and compulsive behaviors seen in Tourette syndrome.

Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...

Adults with type 1 diabetes who initiated treatment with a bionic pancreas at a primary care site experienced similar glycemic benefits as those starting the device through an endocrinologist, ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...